세계의 이식 진단 시장(2025-2035년) : 산업 분석, 시장 규모, 점유율, 성장, 동향, 예측

Transplant Diagnostics Market - Scope of Report

TMR's report on the global transplant diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global transplant diagnostics market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global transplant diagnostics market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the transplant diagnostics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global transplant diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global transplant diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global transplant diagnostics market.

The report delves into the competitive landscape of the global transplant diagnostics market. Key players operating in the global transplant diagnostics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global transplant diagnostics market profiled in this report.

Key Questions Answered in Global transplant diagnostics Market Report:

• What is the sales/revenue generated by transplant diagnostics across all regions during the forecast period?
• What are the opportunities in the global transplant diagnostics market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2035?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Transplant Diagnostics Market - Research Objectives and Research Approach

The comprehensive report on the global transplant diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global transplant diagnostics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global transplant diagnostics market.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Transplant Diagnostics Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Product Definition
  • 4.1.2. Industry Evolution / Developments
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Transplant Diagnostics Market Analysis and Forecast, 2017 to 2031

5. Key Insights

• 5.1. Pipeline Analysis
• 5.2. Key Product/Brand Analysis
• 5.3. Key Mergers & Acquisitions
• 5.4. COVID-19 Pandemic Impact on Industry

6. Global Transplant Diagnostics Market Analysis and Forecast, by Screening

• 6.1. Introduction and Definitions
• 6.2. Key Findings/Developments
• 6.3. Market Value Forecast, by Screening, 2017 to 2031
  • 6.3.1. Pre-transplant Diagnostics
  • 6.3.2. Post-transplant Diagnostics
• 6.4. Market Attractiveness, by Screening

7. Global Transplant Diagnostics Market Analysis and Forecast, by Technique

• 7.1. Introduction and Definitions
• 7.2. Key Findings/Developments
• 7.3. Market Value Forecast, by Technique, 2017 to 2031
  • 7.3.1. Molecular Assay
  • 7.3.2. Non-molecular Assay
  • 7.3.3. 7.4 Market Attractiveness, by Technique

8. Global Transplant Diagnostics Market Analysis and Forecast, by Application

• 8.1. Introduction and Definitions
• 8.2. Key Findings/Developments
• 8.3. Market Value Forecast, by Application, 2017 to 2031
  • 8.3.1. Solid Organ Transplantation
    • 8.3.1.1. Kidney
    • 8.3.1.2. Liver
    • 8.3.1.3. Heart
    • 8.3.1.4. Lungs
    • 8.3.1.5. Pancreas
    • 8.3.1.6. Small Bowel
  • 8.3.2. Stem Cell Transplantation
• 8.4. Market Attractiveness, by Application

9. Global Transplant Diagnostics Market Analysis and Forecast, by Products & Services

• 9.1. Introduction and Definitions
• 9.2. Key Findings/Developments
• 9.3. Market Value Forecast, by Products & Services, 2017 to 2031
  • 9.3.1. Reagents & Consumables
  • 9.3.2. Instruments
  • 9.3.3. Software & Services
• 9.4. Market Attractiveness, by Products & Services

10. Global Transplant Diagnostics Market Analysis and Forecast, by End-user

• 10.1. Introduction and Definitions
• 10.2. Key Findings/Developments
• 10.3. Market Value Forecast, by End-user, 2017 to 2031
  • 10.3.1. Hospitals & Transplant Centers
  • 10.3.2. Research Laboratories
  • 10.3.3. Others
• 10.4. Market Attractiveness, by End-user

11. Global Transplant Diagnostics Market Analysis and Forecast, by Region

• 11.1. Key Findings
• 11.2. Market Value Forecast, by Region, 2017 to 2031
  • 11.2.1. North America
  • 11.2.2. Europe
  • 11.2.3. Asia Pacific
  • 11.2.4. Latin America
  • 11.2.5. Middle East & Africa
• 11.3. Market Attractiveness, by Region

12. North America Transplant Diagnostics Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast, by Screening, 2017 to 2031
  • 12.2.1. Pre-transplant Diagnostics
  • 12.2.2. Post-transplant Diagnostics
• 12.3. Market Attractiveness, by Screening
• 12.4. Market Value Forecast, by Technique, 2017 to 2031
  • 12.4.1. Molecular Assay
  • 12.4.2. Non-molecular Assay
• 12.5. Market Attractiveness, by Technique
• 12.6. Market Value Forecast, by Application, 2017 to 2031
  • 12.6.1. Solid Organ Transplantation
    • 12.6.1.1. Kidney
    • 12.6.1.2. Liver
    • 12.6.1.3. Heart
    • 12.6.1.4. Lungs
    • 12.6.1.5. Pancreas
    • 12.6.1.6. Small Bowel
  • 12.6.2. Stem Cell Transplantation
• 12.7. Market Attractiveness, by Application
• 12.8. Market Value Forecast, by Products & Services, 2017 to 2031
  • 12.8.1. Reagents & Consumables
  • 12.8.2. Instruments
  • 12.8.3. Software & Services
• 12.9. Market Attractiveness, by Products & Services
• 12.10. Market Value Forecast, by End-user, 2017 to 2031
  • 12.10.1. Hospitals & Transplant Centers
  • 12.10.2. Research Laboratories
  • 12.10.3. Others
• 12.11. Market Attractiveness, by End-user
• 12.12. Market Value Forecast, by Country/Sub-region, 2017 to 2031
  • 12.12.1. U.S.
  • 12.12.2. Canada
• 12.13. Market Attractiveness Analysis
  • 12.13.1. By Screening
  • 12.13.2. By Technique
  • 12.13.3. By Application
  • 12.13.4. By Products & Services
  • 12.13.5. By End-user
  • 12.13.6. By Country

13. Europe Transplant Diagnostics Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast, by Screening, 2017 to 2031
  • 13.2.1. Pre-transplant Diagnostics
  • 13.2.2. Post-transplant Diagnostics
• 13.3. Market Attractiveness, by Screening
• 13.4. Market Value Forecast, by Technique, 2017 to 2031
  • 13.4.1. Molecular Assay
  • 13.4.2. Non-molecular Assay
• 13.5. Market Attractiveness, by Technique
• 13.6. Market Value Forecast, by Application, 2017 to 2031
  • 13.6.1. Solid Organ Transplantation
    • 13.6.1.1. Kidney
    • 13.6.1.2. Liver
    • 13.6.1.3. Heart
    • 13.6.1.4. Lungs
    • 13.6.1.5. Pancreas
    • 13.6.1.6. Small Bowel
  • 13.6.2. Stem Cell Transplantation
• 13.7. Market Attractiveness, by Application
• 13.8. Market Value Forecast, by Products & Services, 2017 to 2031
  • 13.8.1. Reagents & Consumables
  • 13.8.2. Instruments
  • 13.8.3. Software & Services
• 13.9. Market Attractiveness, by Products & Services
• 13.10. Market Value Forecast, by End-user, 2017 to 2031
  • 13.10.1. Hospitals & Transplant Centers
  • 13.10.2. Research Laboratories
  • 13.10.3. Others
• 13.11. Market Attractiveness, by End-user
• 13.12. Market Value Forecast, by Country/Sub-region, 2017 to 2031
  • 13.12.1. Germany
  • 13.12.2. U.K.
  • 13.12.3. France
  • 13.12.4. Italy
  • 13.12.5. Spain
  • 13.12.6. Rest of Europe
• 13.13. Market Attractiveness Analysis
  • 13.13.1. By Screening
  • 13.13.2. By Technique
  • 13.13.3. By Application
  • 13.13.4. By Products & Services
  • 13.13.5. By End-user
  • 13.13.6. By Country/Sub-region

14. Asia Pacific Transplant Diagnostics Market Analysis and Forecast

• 14.1. Introduction
  • 14.1.1. Key Findings
• 14.2. Market Value Forecast, by Screening, 2017 to 2031
  • 14.2.1. Pre-transplant Diagnostics
  • 14.2.2. Post-transplant Diagnostics
• 14.3. Market Attractiveness, by Screening
• 14.4. Market Value Forecast, by Technique, 2017 to 2031
  • 14.4.1. Molecular Assay
  • 14.4.2. Non-molecular Assay
• 14.5. Market Attractiveness, by Technique
• 14.6. Market Value Forecast, by Application, 2017 to 2031
  • 14.6.1. Solid Organ Transplantation
    • 14.6.1.1. Kidney
    • 14.6.1.2. Liver
    • 14.6.1.3. Heart
    • 14.6.1.4. Lungs
    • 14.6.1.5. Pancreas
    • 14.6.1.6. Small Bowel
  • 14.6.2. Stem Cell Transplantation
• 14.7. Market Attractiveness, by Application
• 14.8. Market Value Forecast, by Products & Services, 2017 to 2031
  • 14.8.1. Reagents & Consumables
  • 14.8.2. Instruments
  • 14.8.3. Software & Services
• 14.9. Market Attractiveness, by Products & Services
• 14.10. Market Value Forecast, by End-user, 2017 to 2031
  • 14.10.1. Hospitals & Transplant Centers
  • 14.10.2. Research Laboratories
  • 14.10.3. Others
• 14.11. Market Attractiveness, by End-user
• 14.12. Market Value Forecast, by Country/Sub-region, 2017 to 2031
  • 14.12.1. China
  • 14.12.2. Japan
  • 14.12.3. India
  • 14.12.4. Australia & New Zealand
  • 14.12.5. Rest of Asia Pacific
• 14.13. Market Attractiveness Analysis
  • 14.13.1. By Screening
  • 14.13.2. By Technique
  • 14.13.3. By Application
  • 14.13.4. By Products & Services
  • 14.13.5. By End-user
  • 14.13.6. By Country/Sub-region

15. Latin America Transplant Diagnostics Market Analysis and Forecast

• 15.1. Introduction
  • 15.1.1. Key Findings
• 15.2. Market Value Forecast, by Screening, 2017 to 2031
  • 15.2.1. Pre-transplant Diagnostics
  • 15.2.2. Post-transplant Diagnostics
• 15.3. Market Attractiveness, by Screening
• 15.4. Market Value Forecast, by Technique, 2017 to 2031
  • 15.4.1. Molecular Assay
  • 15.4.2. Non-molecular Assay
• 15.5. Market Attractiveness, by Technique
• 15.6. Market Value Forecast, by Application, 2017 to 2031
  • 15.6.1. Solid Organ Transplantation
    • 15.6.1.1. Kidney
    • 15.6.1.2. Liver
    • 15.6.1.3. Heart
    • 15.6.1.4. Lungs
    • 15.6.1.5. Pancreas
    • 15.6.1.6. Small Bowel
  • 15.6.2. Stem Cell Transplantation
• 15.7. Stem Cell Transplantation Market Attractiveness, by Application
• 15.8. Market Value Forecast, by Products & Services, 2017 to 2031
  • 15.8.1. Reagents & Consumables
  • 15.8.2. Instruments
  • 15.8.3. Software & Services
• 15.9. Market Attractiveness, by Products & Services
• 15.10. Market Value Forecast, by End-user, 2017 to 2031
  • 15.10.1. Hospitals & Transplant Centers
  • 15.10.2. Research Laboratories
  • 15.10.3. Others
• 15.11. Market Attractiveness, by End-user
• 15.12. Market Value Forecast, by Country/Sub-region, 2017 to 2031
  • 15.12.1. Brazil
  • 15.12.2. Mexico
  • 15.12.3. Rest of Latin America
• 15.13. Market Attractiveness Analysis
  • 15.13.1. By Screening
  • 15.13.2. By Technique
  • 15.13.3. By Application
  • 15.13.4. By Products & Services
  • 15.13.5. By End-user
  • 15.13.6. By Country/Sub-region

16. Middle East & Africa Transplant Diagnostics Market Analysis and Forecast

• 16.1. Introduction
  • 16.1.1. Key Findings
• 16.2. Market Value Forecast, by Screening, 2017 to 2031
  • 16.2.1. Pre-transplant Diagnostics
  • 16.2.2. Post-transplant Diagnostics
• 16.3. Market Attractiveness, by Screening
• 16.4. Market Value Forecast, by Technique, 2017 to 2031
  • 16.4.1. Molecular Assay
  • 16.4.2. Non-molecular Assay
• 16.5. Market Attractiveness, by Technique
• 16.6. Market Value Forecast, by Application, 2017 to 2031
  • 16.6.1. Solid Organ Transplantation
    • 16.6.1.1. Kidney
    • 16.6.1.2. Liver
    • 16.6.1.3. Heart
    • 16.6.1.4. Lungs
    • 16.6.1.5. Pancreas
    • 16.6.1.6. Small Bowel
  • 16.6.2. Stem Cell Transplantation
• 16.7. Market Attractiveness, by Application
• 16.8. Market Value Forecast, by Products & Services, 2017 to 2031
  • 16.8.1. Reagents & Consumables
  • 16.8.2. Instruments
  • 16.8.3. Software & Services
• 16.9. Market Attractiveness, by Products & Services
• 16.10. Market Value Forecast, by End-user, 2017 to 2031
  • 16.10.1. Hospitals & Transplant Centers
  • 16.10.2. Research Laboratories
  • 16.10.3. Others
• 16.11. Market Attractiveness, by End-user
• 16.12. Market Value Forecast, by Country/Sub-region, 2017 to 2031
  • 16.12.1. GCC Countries
  • 16.12.2. South Africa
  • 16.12.3. Rest of Middle East & Africa
• 16.13. Market Attractiveness Analysis
  • 16.13.1. By Screening
  • 16.13.2. By Technique
  • 16.13.3. By Application
  • 16.13.4. By Products & Services
  • 16.13.5. By End-user
  • 16.13.6. By Country/Sub-region

17. Competition Landscape

• 17.1. Market Player - Competition Matrix (By Tier and Size of Companies)
• 17.2. Market Share Analysis, by Company (2022)
• 17.3. Company Profiles
  • 17.3.1. Bio-Rad laboratories, Inc.
    • 17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 17.3.1.2. Product Portfolio
    • 17.3.1.3. Financial Overview
    • 17.3.1.4. SWOT Analysis
    • 17.3.1.5. Strategic Overview
  • 17.3.2. Qiagen N.V.
    • 17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 17.3.2.2. Product Portfolio
    • 17.3.2.3. Financial Overview
    • 17.3.2.4. SWOT Analysis
    • 17.3.2.5. Strategic Overview
  • 17.3.3. F. Hoffmann-La Roche AG
    • 17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 17.3.3.2. Product Portfolio
    • 17.3.3.3. Financial Overview
    • 17.3.3.4. SWOT Analysis
    • 17.3.3.5. Strategic Overview
  • 17.3.4. Thermo Fisher Scientific, Inc.
    • 17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 17.3.4.2. Product Portfolio
    • 17.3.4.3. Financial Overview
    • 17.3.4.4. SWOT Analysis
    • 17.3.4.5. Strategic Overview
  • 17.3.5. Becton, Dickinson and Company
    • 17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 17.3.5.2. Product Portfolio
    • 17.3.5.3. Financial Overview
    • 17.3.5.4. SWOT Analysis
    • 17.3.5.5. Strategic Overview
  • 17.3.6. Ortho Clinical Diagnostics
    • 17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 17.3.6.2. Product Portfolio
    • 17.3.6.3. Financial Overview
    • 17.3.6.4. SWOT Analysis
    • 17.3.6.5. Strategic Overview
  • 17.3.7. Immucor, Inc.
    • 17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 17.3.7.2. Product Portfolio
    • 17.3.7.3. Financial Overview
    • 17.3.7.4. SWOT Analysis
    • 17.3.7.5. Strategic Overview
  • 17.3.8. Illumina, Inc.
    • 17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 17.3.8.2. Product Portfolio
    • 17.3.8.3. Financial Overview
    • 17.3.8.4. SWOT Analysis
    • 17.3.8.5. Strategic Overview
  • 17.3.9. Siemens Healthineers (Siemens AG)
    • 17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 17.3.9.2. Product Portfolio
    • 17.3.9.3. Financial Overview
    • 17.3.9.4. SWOT Analysis
    • 17.3.9.5. Strategic Overview
  • 17.3.10. Agilent Technologies
    • 17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 17.3.10.2. Product Portfolio
    • 17.3.10.3. Financial Overview
    • 17.3.10.4. SWOT Analysis
    • 17.3.10.5. Strategic Overview